Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Cancers|March 28, 2026
Immunotherapies for Breast Cancer: From Checkpoint Inhibition to Emerging Cellular TherapiesIsmini Tsagkaraki, Isaac Gannon, Alexandros Rampotas, et al.European Journal of Case Reports in Internal Medicine|August 14, 2020
A Case of Meningococcal and HSV-2 Meningitis in a Patient Being Treated with Ustekinumab for Pityriasis Rubra PilarisCharalampos I Kalogeropoulos, Konstantinos A Papathanasiou, Ismini Tsagkaraki, et al.Annals of Medicine and Surgery (2012)|April 18, 2017
Is In-Vivo laparoscopic simulation learning a step forward in the Undergraduate Surgical Education?Panteleimon Pantelidis, Michail Sideris, Georgios Tsoulfas, et al.The Indian Journal of Surgery|March 28, 2018
Introducing In Vivo Dissection Modules for Undergraduate Level Trainees: What Is the Actual Benefit and How Could We Make It More Efficient?Michail Sideris, Apostolos Papalois, Korina Theodoraki, et al.Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|December 30, 2017
The Role of Anxiety in Simulation-Based Dexterity and Overall Performance: Does It Really Matter?Fatema Dhaif, Georgios Paparoidamis, Michail Sideris, et al.European Journal of Haematology|January 26, 2021
Efficacy and tolerability of VCD chemotherapy in a UK real-world dataset of elderly transplant-ineligible newly diagnosed myeloma patientsAlexandros Rampotas, Faouzi Djebbari, Fotios Panitsas, et al.Plos One|January 11, 2022
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patientsFaouzi Djebbari, Alexandros Rampotas, Fotios Panitsas, et al.Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|September 10, 2016
Promoting Undergraduate Surgical Education: Current Evidence and Students' Views on ESMSC International Wet Lab CourseMichail Sideris, Apostolos Papalois, Korina Theodoraki, et al.Hematology (Amsterdam, Netherlands)|June 6, 2022
Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world studyFaouzi Djebbari, Alexandros Rampotas, Grant Vallance, et al.Hemasphere|June 2, 2022
Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World DatasetFaouzi Djebbari, Alexandros Rampotas, Grant Vallance, et al.Pageof 1